Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis

Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis

This study shows that the skin-microbiome in patients with eczema/atopic dermatitis is characterized by overgrowth of S. aureus bacteria. More overgrowth was linked to more severe symptoms. On the other hand a different bacterial species, S. epidermidis, was associated with reduced eczema severity. The study supports eczema treatment through elimination of only S. aureus. While antibiotics do not distinguish between 'good' and 'bad’ bacteria, this approach is possible with Staphefekt, the active ingredient in Gladskin Eczema products.

Read the article

Share this article

Bekijk een volgend artikel

Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins
Staphefekt – intervening early in the Colonisation Infection Continuum with endolysins
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with theTopical Endolysin Staphefekt SA.100: A Report of 3 Cases
Successful Treatment of Chronic Staphylococcus aureus-Related Dermatoses with theTopical Endolysin Staphefekt SA.100: A Report of 3 Cases
Shopping Cart
×

Total-

Subtotal